# Park Medi World (NSE: PARKHOSPS) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/PARKHOSPS · Pivot · prices to 22 Oct 2026

Park Medi World (NSE: PARKHOSPS) closed at ₹220.45 on 22 Oct 2026, down 0.74% on the day. With a market capitalisation of ₹9,522 Cr, it ranks 560th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

At its last close the stock traded at 32.1× trailing earnings, against a return on equity of 12.8% in FY26. Its 52-week range is ₹138.10 (18 Dec 2025) to ₹305.00 (1 Jul 2026); the last close is 27.7% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹476 Cr (+19.4% year on year) and net profit ₹89 Cr (+46.2%), on a consolidated basis. Promoters held 82.89% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹220.45 |
| Market cap | ₹9,522 Cr |
| P/E (trailing) | 32.1 |
| ROE | 12.8% (FY26) |
| ROCE | 18.1% (FY26) |
| Debt to equity | 0.11 |
| 52-week high | ₹305.00 (1 Jul 2026) |
| 52-week low | ₹138.10 (18 Dec 2025) |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹476 Cr | +19.4% | ₹89 Cr | +46.2% | ₹2.05 |
| Q4 FY26 | ₹460 Cr | +30.1% | ₹77 Cr | +46.6% | ₹1.78 |
| Q3 FY26 | ₹410 Cr | +17.8% | ₹53 Cr | +15.8% | ₹1.35 |
| Q2 FY26 | ₹410 Cr | — | ₹79 Cr | — | ₹2.04 |
| Q1 FY26 | ₹398 Cr | — | ₹61 Cr | — | ₹1.58 |
| Q4 FY25 | ₹354 Cr | — | ₹52 Cr | — | ₹1.36 |
| Q3 FY25 | ₹348 Cr | — | ₹46 Cr | — | ₹1.19 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹1,394 Cr | ₹213 Cr |
| FY24 | ₹1,231 Cr | ₹152 Cr |
| FY23 | ₹1,255 Cr | ₹228 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 82.89%
- Foreign institutions: 0.82%
- Domestic institutions: 8.95%
- Non-institutions: 7.33%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Metropolis Healthcare](https://app.pivotnow.in/stock/METROPOLIS) | ₹532.25 | ₹11,035 Cr | 57.9 | — |
| [Akums Drugs and Pharmaceuticals](https://app.pivotnow.in/stock/AKUMS) | ₹690.85 | ₹10,874 Cr | 41.5 | — |
| [Blue Jet Healthcare](https://app.pivotnow.in/stock/BLUEJET) | ₹499.60 | ₹9,456 Cr | 35 | — |
| [Viyash Scientific](https://app.pivotnow.in/stock/VIYASH) | ₹214.90 | ₹9,388 Cr | 53.6 | — |
| [Strides Pharma Science](https://app.pivotnow.in/stock/STAR) | ₹1,017.30 | ₹9,377 Cr | 16.9 | — |
| [Yatharth Hospital & Trauma Care Services](https://app.pivotnow.in/stock/YATHARTH) | ₹932.10 | ₹8,981 Cr | 51.2 | — |

## Questions and answers

### What is the share price of Park Medi World today?

Park Medi World (NSE: PARKHOSPS) last closed at ₹220.45 on 22 Oct 2026. Its 52-week high is ₹305.00 and its 52-week low is ₹138.10.

### What is the market cap of Park Medi World?

Park Medi World's market capitalisation is ₹9,522 Cr (₹9,522 Cr) at the 22 Oct 2026 close, ranking 560th among the NSE companies Pivot tracks.

### What is the P/E ratio of Park Medi World?

Park Medi World trades at a trailing P/E of 32.1. The median P/E of the 6 closest Pharma & Healthcare peers by market cap is 51.2.

### What is the ROE and ROCE of Park Medi World?

Return on equity was 12.8% in FY26 and return on capital employed was 18.1% in FY26 (consolidated figures).

### Is Park Medi World a debt-free company?

No. Park Medi World's debt-to-equity ratio was 0.11 in FY26, with total debt of ₹19 Cr.

### What were Park Medi World's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Park Medi World reported revenue of ₹476 Cr, +19.4% year on year, and net profit of ₹89 Cr, +46.2% year on year.

### What is the shareholding pattern of Park Medi World?

As of 30 Jun 2026: promoters 82.89%, foreign institutions 0.82%, domestic institutions 8.95%, non-institutions 7.33%.

### Who are Park Medi World's competitors?

The listed Pharma & Healthcare companies closest to Park Medi World by market cap are Metropolis Healthcare, Akums Drugs and Pharmaceuticals, Blue Jet Healthcare, Viyash Scientific, Strides Pharma Science and Yatharth Hospital & Trauma Care Services.

### Is Park Medi World a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Park Medi World's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on PARKHOSPS against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.